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Background. During HIV-1 infection coreceptor switch from CCR5- (R5)- to CXCR4 (X4)-using viruses is associated with disease
progression. X4 strains of HIV-1 are highly cytopathic to immature thymocytes. Virtually no studies have evaluated the HIV-1
quasispecies present in vivo within thymic and lymphoid tissues or the evolutionary relationship between R5 and X4 viruses in
tissues and peripheral blood. Methodology/Principal Findings. High-resolution phylodynamic analysis was applied to virus
envelope quasispecies in longitudinal peripheral blood mononuclear cells (PBMCs) and lymphoid and non-lymphoid tissues
collected post mortem from therapy naı ¨ve children with AIDS. There were three major findings. First, continued evolution of R5
viruses in PBMCs, spleen and lymph nodes involved multiple bottlenecks, independent of coreceptor switch, resulting in fitter
quasispecies driven by positive selection. Second, evolution of X4 strains appeared to be a sequential process requiring the
initial fixation of positively selected mutations in V1-V2 and C2 domains of R5 variants before the emergence of high charge V3
X4 variants. Third, R5 viruses persisted after the emergence of CXCR4-using strains, which were found predominantly but not
exclusively in the thymus. Conclusions/Significance. Our data indicate that the evolution of X4 strains is a multi-step,
temporally structured process and that the thymus may play an important role in the evolution/amplification of coreceptor
variants. Development of new therapeutic protocols targeting virus in the thymus could be important to control HIV-1
infection prior to advanced disease.
Citation: Salemi M, Burkhardt BR, Gray RR, Ghaffari G, Sleasman JW, et al (2007) Phylodynamics of HIV-1 in Lymphoid and Non-Lymphoid Tissues
Reveals a Central Role for the Thymus in Emergence of CXCR4-Using Quasispecies. PLoS ONE 2(9): e950. doi:10.1371/journal.pone.0000950
INTRODUCTION
Infection of target cells by human immunodeficiency virus type 1
(HIV-1) requires binding of the viral surface protein gp120 to the
cellular surface protein CD4 and chemokine receptors CCR5 or
CXCR4 [1]. R5 viruses using the CCR5 coreceptor represent the
predominant viral quasispecies during the early and chronic
phases of the infection [2,3]. X4 viruses using the CXCR4
coreceptor appear at a later stage in about 50% of individuals
infected by HIV-1 subtype B and are associated with accelerated
disease progression [4,5]. The reasons for coreceptor evolution
during the course of infection and the origin and evolution of X4
strains are not fully understood, although several hypotheses have
been proposed [6]. Appearance of X4 viruses might reflect
emergence of quasispecies sequestered in tissues at the time of
infection [7] or evolution de novo from R5 viruses [8–10].
The primary genetic determinants of HIV-1 coreceptor use are
concentrated within the 35-amino acid hypervariable V3 loop of
the envelope protein gp120 [11–13]. Although a small number of
basic amino acid substitutions in V3 may be sufficient for changes
in coreceptor preference, combinations of V3 mutations can lead
to major loss of entry fitness in culture, unless compensated by
mutations in or near V1-V2 in gp120 [14], indicating that
complex, discontinuous determinants contribute to X4 coreceptor
use, at least on certain cell types [9,15,16].
Continuing HIV-1 replication in anatomic or cellular reservoirs
and release of latent virus from infected reservoirs can contribute
to viral rebound following interruption of combination anti-
retroviral therapy (ART) [17,18]. Genital tissues and blood appear
to serve as distinct reservoirs harboring latent HIV-1 during
prolonged drug therapy [19,20], while the brain is a viral
compartment harboring HIV-1 subpopulations with specific
genetic characteristics [21–26]. CD4 T lymphocytes in infants
and children predominantly express CD45RA, whereas in adults
about equal ratios of CD45RA or CD45RO are expressed [27].
Only a subset of activated CD4 CD45RO T cells express CCR5,
while the preponderance of CD4 T-lymphocytes, independent of
CD45 isoform, express CXCR4 coreceptors [27,28]. The thymus
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expressing CXCR4, but relatively limited CCR5-expressing cells,
implicating the thymus as a critical compartment for HIV-1
pathogenesis [29–32]. X4 viral strains are highly cytopathic to
immature thymocytes ex vivo [33]. Within HIV-1 infected
individuals, significant reduction in thymocyte proliferation,
output and function occurs in the absence of ART [34,35], while
HIV-induced destruction of the thymus decreases the capacity for
T-cell immune reconstitution resulting in rapid disease progression
in infected children [36]. Despite the importance of X4 strains for
pathogenesis, virtually no studies have evaluated coreceptor use or
the evolutionary patterns across hypervariable regions of HIV-1
env quasispecies infecting the thymus in vivo [37].
Recently, a ‘‘phylodynamic’’ framework using phylogeny and
coalescence theory was developed and applied to study evolution-
ary dynamics of pathogens within infected hosts [26,38]. In the
present work, we applied high-resolution phylodynamics to analyze
HIV-1 subpopulations (virodemes) infecting the thymus, lymphoid
and non-lymphoid tissues that may act as viral compartments
and/or reservoirs [24], and longitudinal peripheral blood mono-
nuclear cells (PBMCs) from HIV-1 infected children. The goal was
to track the tempo and mode of appearance of X4 strains in vivo,t o
investigate the role of the thymus, and to uncover the direction of
viral gene flow among tissues.
RESULTS
Characterization of HIV-1 viral quasispecies in
tissues and peripheral blood
In each subject V3 amino acid residues revealed a mixture of
sequences with low or high net charge predicting, as confirmed by
two independent algorithms, CCR5 or CXCR4 coreceptor use
respectively [39–41]. Three envelope sequences from the thymus,
for which the two algorithms gave discordant results, were
characterized by functional analysis with single-cycle, Env-
pseudotyped viruses [9]. Two (from subject S1 and S2, re-
spectively) used the CXCR4 coreceptor exclusively, while one
(from subject S4) used both CCR5 and CXCR4 coreceptors.
Maximum likelihood (ML) phylogenetic trees estimated from
the V1-V3 alignments of sequences sampled at the time of death
from four subjects displayed significant branches among the
quasispecies independent of length of infection (Figure 1). In subjects
S1, S2 and S3 a well-supported subclade of R5-using viral variants
was localized in PBMCs and distinct from quasispecies in
contemporaneous tissues where X4 and R5 variants commingled
(Fig. 1a, 1b, and 1c). X4-using strains were identified exclusively in
the thymus from subjects S1 and S3, in thymus and PBMCs from
subject S2, and in thymus, lymphoid tissues and peripheral
lymphocytes from subject S4. Sporadic X4 strains were intermixed
with R5 ones in patients S1 (Figure 1a) and S3 (Figure 1c). In
contrast, a well-supported monophyletic clade ofX4 strains emerged
from an R5 population in patients S2 (Figure 1b) and S4 (Figure 1d).
In all cases, X4 variants always clustered on branches that appeared
to emerge from R5 ancestors. The tree inferred for sequences from
each subject included at least one significantly supported branch
within the R5 lineage, suggesting that emergence of successful viral
subpopulations may require selective pressures not exclusively linked
to evolution of V3 variants with altered coreceptor use.
Analysis of recombinant sequences
HIV-1 frequently recombines in vivo [42–44]. Since intra-patient
recombination would lead to the creation of mosaic genomes
violating the tree-like assumption of evolution, we carefully checked
for recombinant sequences within our data sets before performing
high-resolution phylogeneticanalysis.MLtreesinferredfromV1-V2
or C2-V3 domains were identical for S1 and S3, indicating no
obvious intra-patient recombination. The finding was confirmed by
the PHI test for recombination (p.0.05). In contrast, six sequences
(10.9%)from S2and 47 (31.3%) fromS4clustered indifferent clades
dependingonthedomainused toinferthetrees.Significantevidence
of recombination was detected by the PHI test in both S2 and S4
alignments (p,10
26). When putative recombinant sequences were
removed from S2 and S4 alignments, the PHI test was no longer
significant(p.0.05).RecombinantsequencesofR5orX4phenotype
were predominantly detected in tissue samples rather than
peripheral lymphocytes (Table S1). In subject S4 about two-thirds
of the recombinant sequences were found in the brain. It is
important to notice that the low rate of PCR-mediated recombina-
tion (,2% per 1000 nucleotides) [45,46], and the significantly
different distribution of recombinant sequences in different tissues
makes highly unlikely that PCR-recombinants, if any, may have
biased the results of the analysis.
Recombination breakpoints were mapped by bootscanning. In
all 53 recombinant sequences, putative breakpoints were localized
within the C2 domain, while no recombination was found within
V1-V2 (data not shown). Representative bootscannings of two R5
and two X4 sequences are shown in Figure 2. R5 recombinants
originated from ancestral sequences in peripheral blood, while the
X4 recombinants combined R5 V1-V2 sequences from PBMCs
and X4 V3 sequences from the thymus clade (subject S2), or the
thymus/spleen/lymph clade (subject S4). Bootscanning plots for
all other X4 recombinant sequences showed the same pattern
(data not shown).
Tempo and mode of R5 and X4 variants evolution
during infection
Subjects S2 and S4 harbored X4 variants both in PBMCs and the
thymus, and were selected for an in depth study of in vivo evolution
of R5 and X4 quasispecies. Non-recombinant sequences in
PBMCs over the course of infection and from terminal tissues
were combined for a high-resolution phylodynamic analysis
[26,38]. The genealogy of HIV-1 V1-V3 sequences, sampled
over two years of infection from subject S2, showed three main
lineages, A, B, and C (Figure 3a). Each lineage was well supported
by .75% Bayesian posterior probability, p values#0.001 in the
zero branch length test, and .70% bootstrap. Moreover, both ML
and Bayesian-based methods inferred the same root for the tree.
Lineage A including the R5 viral sequences from early and late
PBMCs displayed clear temporal structure. Strains from early
PBMC samples passed through an initial population bottleneck,
followed by a second bottleneck leading to the emergence of a new
monophyletic subcluster that included sequences only from late
PBMC samples. HIV-1 sequences from post mortem lung, spleen, and
lymph nodes were exclusively R5, clustered as a separate phyloge-
netic lineage within clade B, and included at least two bottlenecks.
Temporal structure was also evident in clade C where initial
populations of R5 and X4 strains isolated from early PBMCs were
replaced through a bottleneck by a subclade containing only X4
variants from early and late PBMCs and from the thymus. HIV-1
X4 strains isolated from late PBMCs emerged after a second
bottleneck, while the lastbottleneck gave riseto a subclade consisting
exclusively of X4 viral strains from the thymus.
The inferred phylogeny for subject S4 was based on evaluation
of sequences over a period of about 6.5 years and indicated at least
three statistically supported clusters: A, B, and C (Figure 3b). All
viral sequences from PBMCs at sampling time T1 and T2, as well
as from the brain, displayed V3 loops predicted to use the R5
In Vivo Evolution of HIV-1 X4
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PBMC variant at time T2. As in subject S2, sequences of HIV-1
strains from S4 PBMCs at different time points were temporally
structured: PBMCs sampled at time T1 clustered at the base of the
tree, near to the root, and were replaced through a bottleneck by
a new population from samples collected at later time points.
Sequences from brain were exclusively R5 and belonged to
a separate monophyletic clade (clade B in Figure 3b). Clade C
included HIV-1 strains from PBMCs at T3 with contemporaneous
variants in the lung, lymph nodes, spleen and thymus. In contrast,
the monophyletic cluster at the top of the tree included only X4
HIV-1 variants that were found in thymus, lymph nodes, and
spleen. Overall, the structure of the trees from both individuals
suggested a gradual emergence from R5 to X4 sequences through
continuous selection of new variants evolving over time followed
by an expansion after the last bottleneck of the X4 population.
In vivo evolutionary rates of R5 and X4 populations
To test the hypothesis that the expansion of the X4 population of
viruses might be due to an increased replication rate that would
accelerate evolution, molecular clock analysis was used to estimate
the rate of evolution for R5 and for X4 variants. Mean
evolutionary rates of R5 or X4 strains within subject S2 were
not significantly different. The mean evolutionary rate of the R5
strains was 1.17610
22 nucleotide substitutions per site per year
(0.1–2.2610
22 lower and higher 95% highest posterior density,
HPD), while the rate for X4 strains was 1.6610
22 nucleotide
substitutions per site per year (0.7–2.6610
22 lower and higher
95% HPD). Although absence of longitudinal X4 sequences within
subject S4 precluded estimation of evolutionary rates for X4
subpopulations, an evolutionary rate of 2.4610
22 nucleotide
substitutions per site per year (1.2–3.7610
22 lower and higher
95% HPD) was estimated for the S4 R5 strains in PBMCs.
Evolutionary rate for R5 strains in subject S4 were not significantly
different (p,0.001) from the evolutionary rate of either the R5 or
the X4 strains within subject S2.
Selection analysis during population bottlenecks
Multiple viral population bottlenecks within R5 strains preceded
the bottleneck leading to appearance of X4 variants in both
Figure 1. Maximum likelihood trees of HIV-1 V1-V3 sequences from post mortem tissues and PBMCs of different subjects. Branch lengths were
estimated with the HKY+c model and were drawn in scale with the bar at the bottom indicating 0.01 nucleotide substitutions per site. The position of
the root was inferred by maximum likelihood enforcing the molecular clock constraint. One * along a branch represent significant statistical support
for the clade subtending that branch (zero-branch-length test p,0.001 and a bootstrap value .70%). Colored boxes and circles represent different
tissues according to the color table in the figure. Monophyletic clades of PBMCs with R5 sequences are highlighted within solid circles. Broken circles
highlight monophyletic clades of X4 sequences. a. Subject S1. b. Subject S2. c. Subject S3. d Subject S4.
doi:10.1371/journal.pone.0000950.g001
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forces at work during such bottlenecks, we performed a ML-based
selection pressure analysis of the internal branches in the S2 and
S4 genealogy (Figure 4a and 4b). In each case, the best fitting
model was the one that allowed for both positive and negative
selection along the internal branches involved in the bottlenecks
(p,0.05). Estimated dN/dS ratios were greater than 2 (positive
selection) or less than 0.5 (purifying selection) along the internal
branches. In contrast, dN/dS values were not significantly
different from 1 along the internal branches of the clade that
included the R5 HIV-1 quasispecies from the brain of patient S4.
HIV-1 evolutionary dynamics appeared remarkably similar within
both subjects. In general, bottlenecks driven by positive selection
were usually followed by a bottleneck driven by purifying selection.
Genotypic changes associated with selection
To identify amino acid replacements most likely involved in the
adaptive response of the viral quasispecies to selection pressure,
V1-V3 ancestral sequences involved in the major bottlenecks from
patient S2 and S4 were inferred (Figure 4). A similar evolutionary
Figure 2. Recombination breakpoints in HIV-1 V1-V3 recombinant sequences from different subjects. The cladograms (top panels) represent the
main non-recombinant lineages (putative parental sequences) within the maximum likelihood trees of subject S2 and S4. The bootscanning plots
(middle and bottom panel) were obtained for representative HIV-1 V1-V3 recombinant sequences (query sequences). Horizontal axis indicates the
nucleotide position along a query sequence; vertical axis gives the bootstrap support for the clustering of the query sequence and the parental
sequence (or clade) with a matching color in the cladogram. Vertical dotted lines localize potential recombination breakpoints. a Subject S2. Middle
panel: bootscanning plot of an R5 recombinant sequence from early PBMC (PBMC_1t). Bottom panel: bootscanning plot of an X4 recombinant
sequence from early PBMC (PBMC_1t). b. Subject S4. Middle panel: bootscanning plot of an R5 recombinant sequence from late PBMC (PBMC_3t).
Bottom panel: bootscanning plot of an X4 recombinant sequence from thymus.
doi:10.1371/journal.pone.0000950.g002
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variants from an initial R5 population in both subjects (the full V1-
V3 alignment of the ancestral sequences from both subjects is
given in supplemental Figure S1). Sites under positive selection
generally occurred within the N-terminal portion of V1, within
amino acid positions 132-151, and the C-terminal portion of V2,
within positions 188-190, while the few sites under positive
selection in C2 were interspersed along the domain. V3 mutations
under positive selection were distributed across the domain and
often involved replacements with high-charged basic amino acids
along the branches leading to X4 variants. Generally, positively
selected substitutions in V1, V2, and C2 appeared along the
earlier branches of the genealogies (between Anc1/Anc2 of subject
S2 or between Anc1/Anc2, Anc2/Anc3, Anc3/Anc4 of subject
S4), and were fixed in all subsequent viral populations. Selected
substitutions in V3 appeared only after V1-V2 changes along the
late bottlenecks (between Anc3/Anc4 and Anc5/Anc6 of S2 or
between Anc5/Anc6 and Anc7/Anc8 of S4). The mutation from
serine to arginine at position 306, which is associated with
coreceptor use [47], appeared in the ancestral sequences at the
origin of X4 lineages (between Anc5/Anc6 in S2 and Anc7/Anc8
in S4). Position 268 in C2 was also under positive selection in both
subjects, although in one case G268E appeared during an early
bottleneck within the R5 population (subject S4), while in a second
case, E268K appeared during a late bottleneck within the X4
population (subject S2).
Migration analysis
While viral sequences from the thymus of subject S2 were X4,
mixtures of R5 and X4 quasispecies were found in the thymus and
other lymphoid organs from subject S4. To assess the HIV-1
population dynamic within patient S4, the direction of gene flow
among virodemes in late PBMC samples and post-mortem tissues was
tracked (Figure 5). Sequences from the brain represented a separate
compartment of R5 strains [21–26], and were not included in the
gene-flow analysis. Migration events among different tissues were
significantly less than those expected from a random model in
which each virodeme is freely diffusible and equally likely to
exchange virus with any other one (p,0.0001). Results supported
a model of restricted gene-flow within viral subpopulations in the
thymus and other tissues (Figure 5). PBMCs and thymus
accounted for about 86% of total HIV-1 gene outflow, with
53% from PBMCs (R5 sequences) and 33% from thymus (both R5
and X4 sequences).
DISCUSSION
Studies of HIV-1 evolution in vivo have focused primarily on
a ‘‘whole body’’ approach, where viral evolution is mainly inferred
from cell-free or cell-associated HIV-1 genomes in blood or,
occasionally, within one or two tissues [3,19–21,23,24,26]. In
contrast, our study included detailed mapping of the evolutionary
patterns of HIV-1 virodemes in blood, as well as lymphoid and non-
lymphoid tissues, and applied phylogenetic and population genetic
Figure 3. Maximum likelihood trees of HIV-1 V1-V3 sequences from longitudinal PBMCs and post mortem tissues of different subjects. Branch
lengths were estimated with the HKY+c model and drawn in scale with the bar at the bottom indicating 0.1 nucleotide substitutions per site. The
trees were rooted by maximum likelihood enforcing a molecular clock and taking into account different sampling dates. One * along a branch
represent significant statistical support for the clade subtending that branch (zero-branch-length test p,0.001; Bayesian posterior .0.75, and/or
bootstrap value .70%). Colored boxes and circles represent different tissues according to the color table to the left of each tree. Internal thick edges
indicate population bottlenecks a. Patient S2. PBMC 1t and 2t were sampled 15 and 22 months after birth, respectively. Other tissues were sampled
post mortem 26 months after birth. The main statistically supported clades, designated A, B, and C are highlighted within broken boxes. The solid box
within clade C highlights X4 sequences. b. Patient S4. PBMC 1t, 2t, and 3t were sampled 3, 22, and 77 months after birth, respectively. The other
tissues were sampled post mortem 77 months after birth. The main statistically supported clades, designated A, B, and C are highlighted by broken
boxes. The solid box within clade C highlights X4 sequences.
doi:10.1371/journal.pone.0000950.g003
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Most studies have focused almost exclusively on the V3 loop as the
genetic marker, while none tested for positive selection in the
internal branches of reconstructed genealogies, which is a hallmark
of ancestral episodic selection leading to adaptive response [48].
Inclusion of env V1-V2 domains coupled with internal branch tests
for positive selection in our analysis was critical to uncover
episodic selection within HIV-1 quasispecies.
The role of selection and random genetic drift in the in vivo
evolution of HIV-1 envelope and in the emergence of CXCR4
variants associated with rapid disease progression has been
debated for some time with some evidence supporting each model
[3,49,50]. In our study, positive selection involving amino acid
residues in the V1, V2 and C2 domains was detected before the
emergence of X4 strains, i.e. independent of coreceptor switch. In
contrast, the ancestral sequences at the origin of the X4 strains in
the thymus and other lymphoid organs contained amino acid
replacements in V3 leading to increase net charge of the V3 loops.
The natural history of HIV-1 among the infected subjects
seemed to be defined by sequential population bottlenecks
characterized by temporally ordered patterns of amino acid
substitutions. Within each individual X4 variants evolved de novo
from R5 ancestors ruling out the hypothesis of long term
sequestration of transmitted X4 variants. Although, in general,
different spectra of amino acid replacements in the V1-C2 gp120
domains developed in each individual, sites under positive
selection in early bottlenecks were generally restricted within the
N-terminal portion of V1 and the C-terminal portion of V2. Three
positions in V2, C2, and V3, were found to be under positive
selection across subjects. Substitutions that accumulated in specific
amino acid residues in vivo were identical to amino acid changes
that developed during in vitro evolution [14]. In vitro, combinations
of V3 substitutions can lead to major loss of entry fitness or even
lethality unless compensated by mutations in or near V1-V2
[14,51]. Our study provides evidence that changes outside the V3
domain may be essential for setting the background for the
emergence HIV-1 X4 strains in vivo, in agreement with reports
indicating that other Env regions outside V3 contribute to CXCR4
coreceptor use and cell tropism [9,14–16]. Overall, our data
suggest that the evolution of HIV-1 envelope involved a complex,
but nonetheless ordered and potentially restricted, developmental
program that was recapitulated in different individuals.
In addition to amino acid substitutions in V1-C2, recombina-
tion was detected between V1-V2 and V3 in two individuals.
Rather than random distribution of putative breakpoints in the
recombinants, essentially all sequences had crossover localized to
the C2 region. Evolution of HIV-1 in the brain of one subject was
highly compartmentalized and limited to CCR5-using variants, in
agreement with previous findings [26,52]. An elevated recombi-
nation rate among the R5 sequences in the brain, which our data
identified, would be consistent with a long independent evolution
of a segregated viral subpopulation in a separate compartment.
Since only post mortem samples were available from brain tissue,
phylogenetic analysis could not exclude earlier input of viral
sequences and turnover similar to PBMCs. Analysis of X4 strains
of recombinant origin showed that recombination always occurred
within C2 between ancestral V1V2 sequences of R5 phenotype
from PBMCs and ancestral V3 sequences of X4 phenotype from
Figure 4. Selection pressure in HIV-1 V1-V3 during intra-patient viral population bottlenecks. Rooted Bayesian phylogenetic trees were obtained
using the SRD06 relaxed clock model. Branch lengths were drawn in scale with the bar at the bottom indicating 0.01 nucleotide substitutions per site.
Triangles represent clades for which statistically unsupported internal branches were collapsed. Ancestral (Anc) sequences were reconstructed by
maximum likelihood. Internal branches under significant positive (dN/dS.2) or negative (dN/dS,0.05) selection are drawn in thick red and black
lines, respectively. Open circles emphasize the parent (ancestral sequence before the bottleneck) and child (ancestral sequence following the
bottleneck) nodes. Specific amino acid positions (according to the HXB2 HIV-1 reference sequence) under positive selection within ancestral
sequences are given in the tables at the bottom of each tree. Sequences with predicted X4 coreceptor use are indicated. a. Subject S2. Longitudinal
PBMC and post mortem tissue samples were the same used for the tree in Figure 2a. b. Subject S4. Longitudinal PBMC and post mortem tissue
samples were the same, with the exclusion of sequences from brain, used for the tree in Figure 2b.
doi:10.1371/journal.pone.0000950.g004
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the amplification of CXCR4-using strains.
We also found evidence of bottlenecks characterized by strong
purifying selection, after a positive selection episode, suggesting the
presence of temporary adaptive peaks in the fitness landscape. In
fact, it is expected that if a population reaches a local high-fitness
peak, most of the variants in the next generation would be
removed by purifying selection or genetic drift. Emergence of fitter
HIV-1 strains through the bottlenecks could be due to multiple
selective factors: antiretroviral therapy, cellular immune control,
change in target cell populations or change in host milieu favoring
X4 variants [53], and/or emergence of viral variants with
enhanced entry efficiency. In the subjects in our study, positive
selection occurred in the absence of combination antiretroviral
treatment, ruling out drug selective pressure. All patients had
severely suppressed CD4 T cells and none of the known B-cell
epitopes (listed at the Los Alamos HIV databases) were localized in
the V1-V3 region of sequences from any of our subjects, arguing
against immune control as a major selection factor, although lack
of immunity, as found in the SIV model, may provide a selective
advantage [54]. Our data are consistent with a model of enhanced
viral entry efficiency combined with host milieu as major selective
pressures driving episodic selection.
The results obtained in the present work also point to the
potential importance of the thymus for the evolution/amplification
of the X4 coreceptor use. Thymocytes express high levels of CD4
and CXCR4 and a transcriptionally active environment that
promotes viral replication [55]. Trafficking of lymphocytes
between thymus and secondary lymphoid tissues is highly
regulated and typically unidirectional [56]. The finding in one of
the subjects that HIV-1 X4 gene flow was from thymus to
lymphoid tissues, but not vice versa, is consistent with trafficking
patterns of thymocytes and implicates X4-infected thymocytes as
a potential mechanism for systemic dissemination of X4 variants.
Studies based on experimental observations and mathematical
models suggest that the increased turnover rate of naı ¨ve T-cells
over time in HIV-1 infected patients could be a consequence of
progressive depletion of memory T-cells in the periphery, and may
explain the increased fitness of X4 viruses and their emergence in
about 50% of the individuals during the late stage of the disease
[57]. Our finding that the evolutionary rates of R5 and X4 HIV-1
sub-populations are not significantly different support the
hypothesis that amplification of X4 variants is due to factors
other than an increased rate of evolution and may be linked to the
availability of target cells. In contrast to early reports that thymic
function declines during adolescence and almost disappears in
early adulthood [58], a substantial body of evidence now shows
that the adult thymus retains some thymopoietic function and
continues to produce naı ¨ve T-cells for export to the periphery [59–
62], raising the possibility that our findings from HIV-1 infected
children may be applicable to older individuals, as well.
Some limitations of the present study should be recognized. We
examined HIV-1 quasispecies in thymus tissues from only four
subjects. Since no ante mortem thymic or lymphoid tissues were
available, the exact evolutionary history of the X4 population in
the thymus at earlier time points is uncertain. For example, we
cannot exclude that similar X4 variants may have emerged in
other tissues (such as lymph nodes or spleen) prior to or
concomitant with their appearance in the thymus. Also, the result
of the migration analysis is not informative about the viral flow
during early infection and would require further investigation
using longitudinal samples from different subjects to be confirmed.
However, while it is feasible to collect serial PBMC samples from
earlier time points, serial biopsies of tissues such as thymus and
spleen are hardly an option in human patients. Such a difficulty
points to the importance of animal models, such as SIV-infected
rhesus macaque, to discern the role for the thymus and secondary
lymphoid tissues in evolution of X4 variants.
Further clarification of the key-role of the thymus and other
lymphoid tissues in the evolution/amplification of X4 strains
might have important consequences for the development of
effective therapeutic strategies. R5 coreceptor-blocking agents may
be extremely efficient, during the early stage of the disease, in
avoiding the emergence of the X4 quasispecies associated with
certain types of disease progression. On the other hand, the
development of X4 entry inhibitors and/or drugs able to target the
export of X4 infected T-cells from the thymus could be critical to
control HIV-1 infection in advanced disease stages. If breakdown
of immunity contributes to selection for X4 variants, then
immune-based strategies may delay or prevent amplification of
X4-using viruses independent of the tissue of origin. A detailed
mapping of V1-V3 sites under positive selection associated with
increased viral entry efficiency will lay the foundations for the
development and evaluation of such novel drugs, and our study
has shown the potential power of phylodynamics and high-
resolution phylogeny for accomplishing this important task.
MATERIALS AND METHODS
Subjects and samples
Four pediatric subjects infected by maternal HIV-1 transmission
(S1, S2, and S4) or by neonatal blood transfusion (S3) were
enrolled under a protocol approved by the Institutional Review
Board of the University of Florida, College of Medicine. The
mothers of the children enrolled in the study has already given
consent for the collection and storage of blood and tissue samples
and for collection of clinical data as part of the protocol
Figure 5. HIV-1 migration analysis among different tissues for patient
S4. Each circle is proportional to the percentage of observed migrations
(given within the circle) inferred from the S4 maximum likelihood
cladogram in Supplemental Figure s2. Migration counts less than 1%
were not indicated.
doi:10.1371/journal.pone.0000950.g005
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tions of HIV-1 genetic variability. All patients developed AIDS
before one year of age, and died of AIDS-related illnesses by
8 months (S1), 26 months (S2), 6.5 years (S4), or 7.5 years (S3) of
age. Subjects received antiretroviral therapy with nucleoside
reverse transcriptase inhibitors (NRTI), but no combination
therapy with non-NRTI or protease inhibitors. Tissues including
lung, mesenteric lymph nodes, spleen, thymus, and brain were
obtained post mortem, while peripheral blood mononuclear cells
(PBMCs) were obtained at or near the time of death for all subjects
and over the course of infection for S2, and S4. In patient S4 brain
tissues were mostly sampled from the frontal lobe. DNA was
extracted from cryopreserved PBMC samples as previously
described [63,64]. Tissues were quick frozen in liquid nitrogen
in 50 ml conical tubes and stored at 280uC until processed for
DNA extraction. DNA was extracted from multiple biopsies from
each tissue using the Dneasy tissue extraction kit (QIAGEN,
Valencia, CA) [65]. Several DNA extractions from each tissue
were pooled together, and multiple PCR amplifications were
performed on the combined DNA extraction to ensure represen-
tation of viral sequences within a tissue.
Amplification, cloning and sequencing
The V1-V3 hypervariable region of envelope was amplified using
primers and conditions previously described [66], followed by
ligation into PCR 2.1 vector (Invitrogen, Carlsbad, CA) and
transformation of competent Top10F/(Invitrogen, Carlsbad, CA)
cells. Sequences were prepared with DYEnamic ET dye
terminator cycle sequencing kit for MegaBACE DNA Analysis
Systems (GE Healthcare, Chalfont St. Giles, United Kingdom),
and run on a MegaBACE 1000 (GE Healthcare) in the Genome
Sequencing Service Laboratory at the University of Florida.
Analysis of V1-V3 sequences and coreceptor usage
prediction
Sequences were edited, verified, and entered into HIVbase for
retrieval and analysis [67]. For each domain an amino acid
alignment was obtained manually using our motif-base alignment
method [68] and translated back to nucleotides for further analysis.
HIV-1 subtype was assessed with the Rega HIV subtypying tool
version 2.0 (http://www.bioafrica.net/virus-genotype/html/subty-
pinghiv.html). V1-V3 sequences from all subjects clustered with
subtype B reference sequences. Coreceptor usage was predicted with
two different algorithms: 1. By calculating the net charge of the V3
loop based on number and position of amino acid residues (K+R)-
(D+E) [39]; 2. By using a position-specific scoring matrix (PSSM)
developed for subtype B sequences [40,41]. Both methods gave the
same results except for three sequences for which coreceptor usage
had to be determined experimentally (see below).
Determination of coreceptor usage and actual
phenotype
The V1-V5 hypervariable region of envelope of each strain was
amplified as described previously [66]. V1-V5 sequences were
cloned into pcDNA expression vectors and used to generate single-
cycle viruses tagged with luciferase (luc), as previously described
[9,66]. To determine coreceptor use and cell tropism, PBMC,
monocyte-derived macrophages, and MT-2 cells were infected with
V1-V5 single-cycle env pseudo-typed viruses in the absence or
presence of monoclonal antibody specific for either CCR5 (2D7) or
CXCR4 (12G5) (AIDS Research and Reference Reagent program,
Division of AIDS, NIAID, NIH). Virus phenotype was defined [69].
Recombination analysis
HIV-1 gp120 env sequences (V1 to V3 domains) from all
individuals were evaluated in a single phylogenetic tree that
verified the integrity of the data. Separate phylogenetic trees for
V1-V2 and C2-V3 domains were also obtained to detect putative
recombinant sequences that may cluster differently in different
trees. The presence of recombination was confirmed with the PHI
test, which is based on the notion of refined incompatibility score
[70], and it is implemented in SplitsTree package version 4.8 [71].
Extensive simulation studies and comparison with other available
methods have shown that not only the PHI test is extremely
powerful in detecting recombination, but it is also the method
producing the lowest number of false positives [70]. Significance of
the PHI statistic for the presence of recombination is assessed with
the normal approximation of a permutation test where, under the
null hypothesis of no recombination, sites along the alignment are
randomly permuted to obtain the null distribution of PHI: p,0.05
indicate significant presence of recombination [69].
Mapping recombination breakpoints
Recombinant sequences were analyzed with the bootscanning
method implemented in the Simplot package [72] to locate putative
recombination breakpoints. Bootscanning infers phylogenetic trees
using a sliding window along an alignment including a query
sequence (the putative recombinant sequence) and putative parental
(non-recombinant) sequences. For each tree along the alignment
1000 bootstrap replicates are generated and the bootstrap support
for the clustering of the query sequence with each of the pre-defined
parental groups is recorded. Bootscanning plots, like the ones
showed inFigure 3,displayhow thebootstrap support (y-axis)for the
clusteringof thequerysequence with the parentalsequenceschanges
along the alignment (x-axis). Since recombination leads to the
creation of mosaic genomes originated from different ancestors,
a recombination event can be detected by the ‘‘jumping’’ of the
query sequence between highly supported phylogenetic clades in
trees obtained from different genomic regions [73]. Bootscanning
plots were obtained using a window of 200 nucleotides sliding
forward in steps of 20 nucleotides. Trees were inferred by NJ using
HKY estimated distances with a transition transversion ratio
empirically estimated by maximum likelihood for each window.
Phylogenetic Analysis of non-recombinant data sets
A total of 33 sequences for S1 (median per tissue 8, range 5 to 13);
49 sequences for S2 (median/tissue 9, range 6 to 12); 17 sequences
for S3 (median/tissue 8, range 1 to 17); and 103 sequences for S4
(median/tissue 15, range 3 to 35) were analyzed. The best fitting
nucleotide substitution model was tested with a hierarchical
likelihood ratio test, using a neighbor-joining (NJ) tree with
LogDet corrected distances [74]. Maximum likelihood (ML) trees
were then inferred with the selected model (HKY+c, 8 categories,
for all data sets) and ML-estimated substitution parameters. The
heuristic search for the best tree was performed using an NJ tree as
starting tree and the TBR branch-swapping algorithm. Neighbor-
Joining (NJ) trees were also estimated using pair-wise distances
inferred by ML with the best fitting nucleotide substitution model.
Calculations were performed with PAUP* 4.0b10 written by
David L. Swofford. Statistical support for internal branches in the
NJ trees was obtained by bootstrapping (1000 replicates) for the NJ
trees and the ML-based zero branch length test for the ML trees
[74]. Trees were rooted by ML rooting by selecting the rooted tree
with the best likelihood under the molecular clock constraint, or by
outgroup rooting using the earliest PBMC samples as outgroup.
The location of the root was confirmed by inferring rooted
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distributed evolutionary rates as prior. The Bayesian calculation
consisted of 50,000,000 generations Markov Chains Monte Carlo
(MCMC) with sampling every 5000
th generation using the BEAST
software package version 1.4 (http://evolve.zoo.ox.ac.uk/beast/).
Convergence of the MCMC was assessed by calculating the
effective sampling size (ESS) of the combined runs [75]. All
parameter estimates showed significant ESS (.250). Bayesian
trees were also obtained with the program MrBayes v3.1.2, using
the HKY+c model, running in parallel two MCMC for
10,000,000 generations with sampling every 100
th generation.
Convergence was assessed by comparing the average standard
deviation of split frequencies (p,0.0001). Statistical support for
each clade in the Bayesian trees was obtained by calculating clade-
specific Bayesian posterior probabilities with MrBayes. In each
case, ML and Bayesian methods inferred the same topology.
Reconstruction of ancestral sequences and positive
selection analysis
Ancestral amino acid sequences in the genealogy obtained for each
patient were inferred by the maximum likelihood method, using the
codon substitution model M0 [76]. Positive selection analysis was
performed by comparing the different Branch maximum likelihood
codon substitution models using the improved test 2, which tests for
different dN/dS (nonsynonymous/synonymous substitutions) ratios
along given branches of the tree [76,77]. Three different models were
compared: model 0, assuming a single dN/dS for the entire tree;
model 1, assuming a different dN/dS for each branch in the tree, and
model2assumingabaselinedN/dS=1fortheentiretreeandseveral
different dN/dS alongthe branchesofthe majorbottleneckevents in
the genealogy. Model 0, model 1, and model 2 are nested and
a hierarchical likelihood ratio test was used to check which model
fitted the data significantly better [76,77]. Average dN/dS ratios
among maximum likelihood inferred ancestral sequences at the
internal nodes of the significantly supported monophyletic clades of
the trees were also compared. Specific amino acid changes along the
internal branches of the tree were inferred by maximum likelihood.
Calculations were performed with the PAML package [76].
Molecular clock analysis
Ultrametric trees were obtained by enforcing a molecular clock on
the inferred genealogy, and re-estimating the branch lengths and
substitution parameters with maximum likelihood with the pre-
viously selected evolutionary model. The clock hypothesis was tested
with the likelihood ratio test. Evolutionary rates with a strict and
a relaxed clock model using a lognormal distribution as prior [75]
were obtained with the Bayesian framework implemented in the
BEAST program version 1.4, by running 50,000,000 Markov Chain
Monte Carlo MCMC with sampling every 5000
th generation.
Calculating the ESS assessed convergenceofthe MCMCprocedure.
ESS.250 were considered significant.
Gene flow tests and migration counts
The hypothesis of compartmentalization, i.e. the existence of distinct
HIV-1 sub-populations in different tissues, was tested by the Slatkin
and Maddison test for gene flow [78] using the MacClade version 4
program (Sinauer Associates, Sunderland, MA). A one-character
data matrix is obtained from the original data set by assigning to each
taxon in the tree a one-letter code indicating its tissue of origin. Then,
the phylogenetic tree obtained from the nucleotide aligniment is
imported in MacClade and the putative origin of each ancestral
sequence (i.e. internal node) in the tree is inferred with the Fitch
algorithm [79] by finding the most parsimonious reconstruction
(MPR) of the ancestral character (this can be accomplished by
selecting the Trace character option in the Trace menu of MacClade).
The result is a tree colored as in supplemental Figure S2, were each
colored branch represent the tissue of origin of the internal node
(ancestral sequence) or tip node (actual sequence) subtending that
branch. A change in color (i.e. in tissue assignment) between two
branches connected trough a node represent a migration event from
one tissue to another that must have occurred during the genealogical
evolution of the sequences under investigation. The final tree-length,
i.e. the number of observed migrations in the genealogy, computed
by MacClade can be compared to the tree-length distribution of
10,000 trees obtained by random joining-splitting (by selecting the
Character steps/etc option from the Char menu). Observed genealogies
significantly shorter than random trees indicate the presence of
subdivided populations [78]. Specific migrations among different
compartments (states) were traced with the State changes and stasis tool
(MacClade), which counts the number of changes in a tree for each
pair-wise state. When multiple MPRs were present (as in our data
sets), the algorithm calculated the average migration count over all
possible MPRs for each pair. The resulting pair-wise migration
matrix is then normalized to obtain the percentage of observed
migration to/from different tissues in the tree.
SUPPORTING INFORMATION
Table S1 Distribution of HIV-1 V1V3 recombinant sequences
Found at: doi:10.1371/journal.pone.0000950.s001 (0.03 MB
DOC)
Figure S1 V1-V3 multiple alignment of reconstructed ancestral
sequences from patients S2 and S4. Ancestral (Anc) sequences,
corresponding to the internal nodes in the trees in Figure 4, are
aligned with the HIV-1 reference strain HXB2 on top. Blank
spaces indicate gaps. A dash indicates that the amino acid matches
the corresponding position of HXB2. In the V3 loop, red and blue
shadings indicate positively and negatively charged amino acids,
respectively, which are important for the determination of
coreceptor use. Two arrows indicate residues 11 and 25
considered important for coreceptor use (Fouchier et al. 1994).
Specific sites under positive selection are outlined by solid boxes.
Found at: doi:10.1371/journal.pone.0000950.s002 (0.24 MB TIF)
Figure S2 Maximum parsimony migration analysis for patient
S4. Cladogram of HIV-1 sequences from different tissues showing
clade C of the maximum likelihood tree given in Figure 3. The
color of a branch indicates the tissue of origin of the top node
(ancestral sequence) or tip (actual sequence) of that branch
according to the color table in the figure. Tissues of origin for the
internal nodes (ancestral sequences) of the cladogram were
inferred with the Fitch (1971) algorithm.
Found at: doi:10.1371/journal.pone.0000950.s003 (0.28 MB TIF)
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